English  ✓

Français

Session 47:
National HIV prevalence estimates: advantages and limitations of different estimation methods

Wednesday, December 12
2:15 PM - 4:15 PM
Tausi
Serengeti Wing. Ground Floor

Chair: Saidi Kapiga
Discussant: Basia Zaba, London School of Hygiene and Tropical Medicine (LSHTM)

  1. Is HIV seroprevalence declining among women who access PMTCT services? A multi-country analysis.Agbessi Amouzou, Elizabeth Glaser Pediatric AIDS Foundation; Charlotte Colvin, Elizabeth Glaser Pediatric AIDS Foundation; Charles Hoblitzelle, Elizabeth Glaser Pediatric AIDS Foundation; Christian Pitter, Elizabeth Glaser Pediatric AIDS Foundation; Allison Spensley, Elizabeth Glaser Pediatric AIDS Foundation; Catherine Wilfert, Elizabeth Glaser Pediatric AIDS Foundation

  2. Understanding the magnitude and spread of HIV/AIDS epidemic in sub-Saharan Africa: evidence from the demographic and health surveys and AIDS indicator surveysVinod Mishra, Macro International Inc.; Anne R Cross, Macro International Inc.; Bernard Barrere, Macro International Inc.; Rathavuth Hong, Macro International Inc.; Martin T Vaessen, Macro International Inc.

  3. Bias in HIV prevalence estimates from refusals to be tested in seroprevalence surveysGeorges Reniers, Princeton University; Jeff Eaton, Imperial College

  4. Factors contributing to differences in prevalence o HIV/AIDS in South Africa and BangladeshJeroen van Ginneken, Netherlands Interdisciplinary Demographic Institute (NIDI)

Other sessions on HIV and AIDS